| Name | Title | Contact Details |
|---|
Veuu is an inclusive and sustainable FinTech ecosystem for healthcare and is the leader of adjudicating claims at discharge. The Veuu value proposition is explicit. Veuu helps providers arrive at the right code, maintain documentation integrity, evaluate claims for risk of payment and denial, and adjudicates claims, all within seconds. This means higher quality claims resulting from instant payments 7/24/365, reduced costs, external quality, and enhanced reputation. The Veuu ecosystem contains a suite of AI tools that automate, and de-risk known as codeVeuu, riskVeuu, payVeuu, and inVeuu. These tools automate the coding and financial risk associated with claims payments and denials so that providers can be paid the day that the patient leaves the hospital on a non-recourse basis. Veuu data tools are designed for audit defense. Provides now can create on-the-fly modeled insights of claims data, coding data, claims data, payments data, and other data driven results that can inform decision making and help to improve the quality of care. The Veuu tools can be used independently or together as an overall automation and de-risking solution. And if you are a provider that is using Cerner or Epic, you can easily get access to Veuus services, which have been validated and integrated into both EMRs.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
Hotel at Old Town is a locally owned boutique hotel in Wichita, KS. We offer corporate travel rates, group blocks, and downtown studios for extended stay & relocations. With friendly & personalized service we are not just a hotel, but a Wichita Experience.
Bioenergy, Inc. is a Andover, MN-based company in the Business Services sector.
The next-generation AI developer platform unifying the development and deployment of AI for the world.